Clyde F. Phelix

According to our database1, Clyde F. Phelix authored at least 11 papers between 2011 and 2017.

Collaborative distances:
  • no known Dijkstra number2.
  • no known Erdős number3.



In proceedings 
PhD thesis 




MSDC-0160 and MSDC-0602 Binding with Human Mitochondrial Pyruvate Carrier (MPC) 1 and 2 Heterodimer: PPARγ Activating and Sparing TZDs as Therapeutics.
IJKDB, 2017

Mitochondrial Pyruvate Carrier 1 and 2 Heterodimer, In Silico, Models of Plant and Human Complexes: A Comparison of Structure and Transporter Binding Properties.
IJKDB, 2017

Alzheimer's and Parkinson's Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier - Ligand Docking to Screen Natural Compounds Related to Classic Inhibitors.
IJKDB, 2017

Integrating -omics information with biosimulations to assist diagnosis and treatment of diabetes mellitus in silico.
Proceedings of the 2017 IEEE EMBS International Conference on Biomedical & Health Informatics, 2017

Modeling non-clinical and clinical drug tests in Gaucher disease.
Proceedings of the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2016

Integrating information on genomics, transcriptomics, proteomics, and metabolomics into biosimulations for individualized personalized medicine.
Proceedings of the 2016 IEEE-EMBS International Conference on Biomedical and Health Informatics, 2016

Low Dose Pioglitazone Attenuates Oxidative Damage in Early Alzheimer's Disease by Binding mitoNEET: Transcriptome-To-Reactome™ Biosimulation of Neurons.
IJKDB, 2015

In Silico Biosimulation of Isoflurane Effects on Brain Using Transcriptome-To-Metabolome™ Technology: Anesthesia Effects on Rat Amygdala & Cortex Metabolism.
IJKDB, 2015

Biomarkers from biosimulations: Transcriptome-to-reactome™ Technology for individualized medicine.
Proceedings of the 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2014

Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer's Disease.
IJKDB, 2011

In Vivo and In Silico Evidence: Hippocampal Cholesterol Metabolism Decreases with Aging and Increases with Alzheimers Disease - Modeling Brain Aging and Disease.
Proceedings of the Data Mining Workshops (ICDMW), 2011